Charis Eng
Impact in
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
- Endocrinology, Diabetes and Metabolism top 0.05%
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 216
- Genetics 101
- BRCA gene mutations in cancer 48
- Co-authors
- Lois M. Mulligan (38 shared papers)Kristin Waite (18 shared papers)Jessica L. Mester (37 shared papers)Patricia L. M. Dahia (19 shared papers)Hartmut P.H. Neumann (27 shared papers)Mohammed S. Orloff (24 shared papers)Joanne Ngeow (29 shared papers)Catherine S. Healey (12 shared papers)
- Journals
- Human Molecular Genetics (41 papers)The Journal of Clinical Endocrinology & Metabolism (36 papers)The American Journal of Human Genetics (27 papers)Journal of Clinical Oncology (22 papers)Oncogene (21 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Charis Eng
631 papers receiving 44.1k citations
Charis Eng's Hit Papers
Peers
Comparison fields: 5 of 181
- Cancer Research 7.0k
- Endocrinology, Diabetes and Metabolism 7.6k
- Oncology 8.1k
- Molecular Biology 21.8k
- Pathology and Forensic Medicine 4.9k
Countries citing papers authored by Charis Eng
This map shows the geographic impact of Charis Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charis Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charis Eng more than expected).
Fields of papers citing papers by Charis Eng
This network shows the impact of papers produced by Charis Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charis Eng. The network helps show where Charis Eng may publish in the future.
Co-authors
The 25 scholars most cited alongside Charis Eng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 647 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Hit paper breakdown → | 1997 | 1534 |
| 2 | Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A Hit paper breakdown → | 1993 | 1450 |
| 3 | Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association Hit paper breakdown → | 2009 | 862 |
| 4 | Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma Hit paper breakdown → | 2001 | 844 |
| 5 | Catalytic specificity of protein-tyrosine kinases is critical for selective signalling Hit paper breakdown → | 1995 | 806 |
| 6 | The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis Hit paper breakdown → | 1996 | 782 |
| 7 | Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity Hit paper breakdown → | 2007 | 769 |
| 8 | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase Hit paper breakdown → | 1997 | 660 |
| 9 | Lifetime Cancer Risks in Individuals with GermlinePTENMutations Hit paper breakdown → | 2012 | 594 |
| 10 | Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations Hit paper breakdown → | 2005 | 594 |
| 11 | PTEN: One Gene, Many Syndromes Hit paper breakdown → | 2003 | 583 |
| 12 | The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2 Hit paper breakdown → | 1996 | 549 |
| 13 | 1994 | 496 | |
| 14 | 1999 | 424 | |
| 15 | Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma Hit paper breakdown → | 1993 | 407 |
| 16 | 1994 | 397 | |
| 17 | Pheochromocytoma and Paraganglioma Hit paper breakdown → | 2019 | 386 |
| 18 | 2000 | 375 | |
| 19 | 2001 | 368 | |
| 20 | 2000 | 366 |
About Charis Eng
Charis Eng is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Surgery, having authored 647 papers that have together received 45.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (216 papers), Genetic factors in colorectal cancer (54 papers), BRCA gene mutations in cancer (48 papers), Thyroid Cancer Diagnosis and Treatment (41 papers), Neuroendocrine Tumor Research Advances (40 papers), Cancer-related Molecular Pathways (39 papers), Cancer, Hypoxia, and Metabolism (39 papers) and Adrenal and Paraganglionic Tumors (35 papers). The work is most often cited by research in Cancer Research (7.0k citations), Endocrinology, Diabetes and Metabolism (7.6k citations), Oncology (8.1k citations), Molecular Biology (21.8k citations) and Pathology and Forensic Medicine (4.9k citations). Charis Eng has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Lois M. Mulligan, Kristin Waite, Jessica L. Mester, Patricia L. M. Dahia, Hartmut P.H. Neumann, Mohammed S. Orloff, Joanne Ngeow, Catherine S. Healey, Ramon Parsons and Kevin Zbuk. Their work appears in journals such as Human Molecular Genetics, The Journal of Clinical Endocrinology & Metabolism, The American Journal of Human Genetics, Journal of Clinical Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.